相关实验视频

Updated: Jun 17, 2025

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

瘤微环境中的化学物质:对肺癌和免疫疗法的影响

Haebeen Jung¹, Silke Paust¹

¹The Jackson Laboratory for Genomic Medicine, Farmington, CT, United States.

Frontiers in immunology

|August 8, 2024

概括

化基因是癌症免疫治疗的关键,在瘤微环境 (TME) 中引导免疫细胞. 了解它们的不同作用对于改善治疗方法至关重要,特别是肺癌.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

瘤微环境 (TME) 是一个复杂的网络,经常抑制免疫反应,阻碍癌症免疫疗法.
化基因是关键的信号分子,调节免疫细胞活动和在TME内的迁移.
化基因的上下文依赖性要求对其对瘤免疫和转移的影响进行具体评估.

研究的目的:

审查化学因子在瘤免疫和TME内的转移中的多方面的作用.
探索基于化学的癌症免疫疗法研究当前的进展.
专注于化学因子在肺癌中的影响,考虑到其预后不佳和治疗选择有限.

主要方法:

现有关于化学因子,TME和癌症免疫治疗的研究的文献综述.
分析化基因在促进或抑制瘤生长和扩散方面的双重作用.
在各种癌症类型中检查特定的化学因子-连接体-受体相互作用,重点是肺癌.

主要成果:

化基因显著影响TME内的免疫细胞透和功能,影响免疫疗法的有效性.
根据具体的背景,化学基因信号传递可以促进瘤生长和转移,或增强抗瘤免疫力.
肺癌由于其特异性TME特征,为化基因向免疫疗法带来了独特的挑战和机会.

结论:

化基因是抗瘤免疫反应和TME内的转移的关键调节者.
向化基因通路对提高癌症免疫疗法的有效性具有显著的希望,特别是在挑战肺癌等癌症方面.
进一步研究特定环境的化学激素功能对于开发新有效的癌症治疗策略至关重要.

关键词:

癌症癌症癌症癌症癌症化学物质 (chemokines) 是一种化学物质.免疫细胞免疫细胞免疫疗法免疫疗法肺癌是一种肺癌.瘤微环境是一个微环境.

更多相关视频

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...